Health Catalyst, Inc. (HCAT) Bundle
An Overview of Health Catalyst, Inc. (HCAT)
General Summary of Health Catalyst, Inc. (HCAT)
Health Catalyst, Inc. (HCAT) is a leading provider of data and analytics technology and services aimed at healthcare organizations. Founded in 2008, the company has developed a suite of cloud-based data platforms, software analytics applications, and professional services tailored for healthcare providers. As of 2024, Health Catalyst continues to focus on enhancing its offerings to improve clinical, financial, and operational outcomes for its clients.
In 2024, Health Catalyst reported total sales of approximately $227.0 million for the nine months ended September 30, 2024, compared to $220.9 million during the same period in 2023, reflecting a steady growth trajectory.
Company's Financial Performance in the Latest Financial Reports
For the three months ended September 30, 2024, Health Catalyst achieved total revenue of $76.4 million, up from $73.8 million in the same quarter of the previous year. For the nine-month period ending September 30, 2024, total revenue reached $227.0 million, compared to $220.9 million in 2023.
The company's net loss for the three months ended September 30, 2024, was $14.7 million, a decrease from $22.0 million reported in the same quarter of 2023. For the nine months ended September 30, 2024, the net loss was $48.8 million, compared to $87.8 million in the prior year.
Health Catalyst's Adjusted EBITDA improved significantly, with figures of $7.3 million and $18.2 million for the three and nine months ended September 30, 2024, respectively, compared to $2.0 million and $9.7 million for the same periods in 2023.
| Financial Metrics | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenue | $76.4 million | $73.8 million | $227.0 million | $220.9 million |
| Net Loss | ($14.7 million) | ($22.0 million) | ($48.8 million) | ($87.8 million) |
| Adjusted EBITDA | $7.3 million | $2.0 million | $18.2 million | $9.7 million |
Introduction to Health Catalyst as a Leader in the Industry
Health Catalyst stands out as a leader in the healthcare analytics industry, with a strong focus on data-driven decision-making. The company's innovative data platform, Health Catalyst Ignite, is designed to enhance scalability and modularity, allowing healthcare organizations to efficiently manage and analyze their data.
With more than 90% of its revenue being recurring, Health Catalyst demonstrates a robust business model that ensures a predictable revenue stream. The company is well-positioned to capitalize on market trends, with ongoing investments in research and development aimed at maintaining its competitive edge.
In 2024, Health Catalyst has made strategic moves, including the acquisition of Carevive Systems, which positions the company to further enhance its offerings in oncology-focused health technology. As the healthcare landscape continues to evolve, Health Catalyst's commitment to providing measurable ROI for its clients will likely contribute to its sustained success in the industry.
Mission Statement of Health Catalyst, Inc. (HCAT)
Mission Statement Overview
Health Catalyst, Inc. (HCAT) is committed to enabling healthcare organizations to achieve sustainable improvements in clinical, financial, and operational outcomes through data and analytics technology. Their mission statement serves as a guiding principle for the company's long-term goals and strategic initiatives, emphasizing the importance of data-informed decision-making in the healthcare sector.
Core Component 1: Enabling Sustainable Improvements
The first core component of Health Catalyst's mission is to enable sustainable improvements in healthcare outcomes. This reflects their dedication to providing tools and services that help clients achieve measurable progress over time. As of September 30, 2024, Health Catalyst reported total revenue of $76.4 million for the quarter, a slight increase from $73.8 million in the same quarter of 2023. This growth indicates the effectiveness of their solutions in driving client success and enhancing operational efficiencies.
Core Component 2: Data and Analytics Technology
The second component focuses on the utilization of data and analytics technology. Health Catalyst's offerings include cloud-based data platforms, software analytics applications, and professional services. For the nine months ended September 30, 2024, the company generated $226.9 million in total revenue, with the technology segment contributing $143.3 million and professional services accounting for $83.7 million. This revenue structure underscores the critical role that data analytics plays in their mission to improve healthcare delivery.
Core Component 3: Measurable Clinical, Financial, and Operational Improvements
The third core component is the commitment to producing measurable improvements across clinical, financial, and operational dimensions. Health Catalyst's solutions have been pivotal in helping healthcare providers manage data and derive actionable insights. The company's Adjusted EBITDA for the three months ended September 30, 2024, was reported at $7.3 million, significantly up from $2.0 million in the previous year. This increase reflects the positive impact of their technology in fostering operational efficiencies and financial performance for their clients.
| Financial Metric | Q3 2024 | Q3 2023 | Change (%) |
|---|---|---|---|
| Total Revenue | $76.4 million | $73.8 million | +3.5% |
| Technology Revenue | $48.7 million | $46.0 million | +3.7% |
| Professional Services Revenue | $27.7 million | $27.8 million | -0.4% |
| Adjusted EBITDA | $7.3 million | $2.0 million | +265% |
Health Catalyst's mission statement encapsulates their vision of leveraging data to transform healthcare, ensuring that organizations can not only meet immediate operational demands but also thrive in a complex healthcare landscape. The emphasis on measurable improvements across multiple facets of healthcare delivery underscores their commitment to quality and effectiveness in their service offerings.
Vision Statement of Health Catalyst, Inc. (HCAT)
Vision Statement Overview
The vision statement of Health Catalyst, Inc. (HCAT) as of 2024 emphasizes a commitment to transforming healthcare through data and analytics. The company seeks to leverage its technological capabilities to improve patient outcomes and optimize healthcare operations.
Commitment to Transforming Healthcare
Health Catalyst aims to lead the healthcare industry in data-driven decision-making. The vision underscores a dedication to enabling healthcare providers to deliver better care at lower costs. In 2023, the healthcare sector faced significant challenges, including increasing operational costs and a need for improved efficiency. Health Catalyst is positioned to address these challenges through its comprehensive data platform and analytics applications.
Focus on Patient Outcomes
The vision statement articulates a strong focus on improving patient outcomes. Health Catalyst believes that by harnessing data, healthcare organizations can make informed decisions that lead to better health results for patients. In 2024, the company reported a total revenue of $226.98 million for the nine months ended September 30, 2024, reflecting its growing impact in the healthcare sector.
Innovative Technology Solutions
Health Catalyst continues to invest in innovative technology solutions to enhance its offerings. The company's technology segment generated $143.25 million in revenue for the nine months ended September 30, 2024, up from $140.48 million in the same period of 2023. This growth highlights the increasing demand for its analytics applications and data platform.
Strategic Partnerships and Collaborations
To fulfill its vision, Health Catalyst actively pursues strategic partnerships and collaborations with healthcare organizations. These partnerships are aimed at expanding the reach of its technology and improving the integration of data analytics in clinical settings. In 2024, Health Catalyst recognized $12.4 million in revenue from a related party, demonstrating its collaborative approach.
| Financial Metrics | 2023 | 2024 |
|---|---|---|
| Total Revenue (Nine Months Ended September 30) | $220.85 million | $226.98 million |
| Technology Segment Revenue | $140.48 million | $143.25 million |
| Professional Services Revenue | $80.37 million | $83.72 million |
| Net Loss | ($87.83 million) | ($48.83 million) |
Long-term Vision for Healthcare Improvement
Health Catalyst's long-term vision focuses on creating a sustainable model for healthcare improvement. The company aims to empower healthcare providers with tools and insights that foster continuous improvement in care delivery. The Adjusted EBITDA for the nine months ended September 30, 2024, was $18.19 million, indicating progress towards financial sustainability while pursuing its vision.
Conclusion of Vision Components
In summary, Health Catalyst's vision statement for 2024 reflects a comprehensive approach to transforming healthcare. Through its focus on patient outcomes, innovative technology solutions, strategic partnerships, and long-term improvement, Health Catalyst is positioned to make a significant impact in the industry.
Core Values of Health Catalyst, Inc. (HCAT)
Integrity
Integrity is a core value at Health Catalyst, Inc. (HCAT) that emphasizes honesty, transparency, and ethical behavior in all business operations. This value is crucial for building trust with clients and stakeholders.
Health Catalyst demonstrates its commitment to integrity through rigorous compliance programs and transparent reporting practices. For instance, in its financial disclosures, HCAT provides detailed information about its revenue sources and expenses, ensuring stakeholders have a clear understanding of its financial health. As of September 30, 2024, the company reported total revenue of $76.4 million, with a net loss of $14.7 million for the quarter.
Collaboration
Collaboration is another fundamental value that drives Health Catalyst's success. The company fosters teamwork across departments and with clients to achieve shared goals.
Health Catalyst has initiated several collaborative projects, including partnerships with healthcare providers to develop customized analytics solutions. For example, the integration of Carevive Systems, acquired on May 24, 2024, enhances collaborative capabilities in oncology care, allowing for improved patient outcomes through shared data analytics.
Innovation
Innovation is at the heart of Health Catalyst's strategy, focusing on developing cutting-edge technology and solutions that improve healthcare delivery.
In 2024, Health Catalyst launched Health Catalyst Ignite, a next-generation data analytics platform that allows healthcare organizations to leverage modular technology solutions. This platform aims to improve operational efficiencies and enhance patient care while supporting the company's goal of 90% recurring revenue. The company reported Adjusted EBITDA of $7.3 million for Q3 2024, reflecting its commitment to innovative financial management.
Accountability
Accountability is a vital core value that ensures every team member takes responsibility for their actions and decisions.
Health Catalyst's accountability is reflected in its performance metrics and regular assessments of project outcomes. For instance, the company monitors its Dollar-based Retention Rate, which is expected to improve in 2024, indicating a commitment to maintaining client relationships and delivering value.
Customer Success
Customer success is a paramount value at Health Catalyst, focusing on ensuring that clients achieve their desired outcomes using the company's solutions.
The company tracks customer satisfaction and success through various metrics, including client engagement and retention rates. HCAT achieved a total revenue of $226.9 million for the nine months ended September 30, 2024, with significant contributions from existing clients expanding their contracts.
| Core Value | Description | 2024 Metrics |
|---|---|---|
| Integrity | Commitment to ethical practices and transparent reporting. | Net loss of $14.7 million for Q3 2024. |
| Collaboration | Fostering teamwork and partnerships for shared success. | Integration of Carevive Systems into operations. |
| Innovation | Developing cutting-edge technology solutions. | Launch of Health Catalyst Ignite platform. |
| Accountability | Ensuring responsibility for actions and outcomes. | Improvement in Dollar-based Retention Rate expected in 2024. |
| Customer Success | Ensuring clients achieve desired outcomes. | Total revenue of $226.9 million for the nine months ended September 30, 2024. |
Health Catalyst, Inc. (HCAT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Health Catalyst, Inc. (HCAT) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Health Catalyst, Inc. (HCAT)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Health Catalyst, Inc. (HCAT)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.